A Quebec women has died after receiving the AstraZeneca Oxford vaccine that was administered in early April. McMaster University laboratory in Hamilton, Ontario studying blood clots related to the COVID-19 vaccines detected the antibodies that caused the platelet problem which led to the women’s death, according to a CBC news report.
Quebec public health director Dr. Horacio Arruda said, “It’s important to weigh the risk of the vaccination against the much higher risk of serious complications with COVID-19.
“It’s clear that the virus kills. But sometimes unfortunately there are complications,” added Dr. Arruda. “It’s very rare. We knew there was a possibility that this could happen.”
There has been 400,000 Canadians that have received the AstraZeneca COVID-19 vaccine and to date one death. Canadian Health Minister Christian Dubé said, “That is 400,000 Canadians that have less chance of getting COVID-19.”
There was an age limit of 45 years old to 70 years of age. ” Canadian Health Minister Christian Dubé added, “It is unfortunately a risk we have to take.”
At this point there are three other blood clot cases in Canada under investigation to see if it is due to the AstraZeneca Oxford vaccine.